Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients
✍ Scribed by Francisco Plancarte; Armando López-Guillermo; Leonor Arenillas; Silvia Montoto; Eva Giné; Ana Muntañola; Ana Ferrer; Neus Villamor; Francesc Bosch; Lluis Colomo; Olga Balaguer; Elías Campo; Emili Montserrat
- Book ID
- 114793956
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 157 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0902-4441
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND The International Prognostic Index (IPI) is widely used as a predictive model in diffuse large B‐cell lymphoma (DLBCL) patients of all ages and stages. To determine the optimal IPI‐based prognostic system at the time of diagnosis in younger patients with limited‐stage DLB
## Background: Chemotherapy containing anthracycline is the standard initial treatment for aggressive non-hodgkin's lymphoma (nhl), and the international prognostic index (ipi) is widely accepted as the standard tool for determining the prognosis of patients with this disease. however, the data on